Chad Watts, MD
Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1124314935
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $57,948 of the $77,820 with a category attached, or 74.5%. Smith+Nephew accounts for 92.7% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $42,880, 7.3 times the $5,851 reported in 2019.
Across 98 payments — averaging $794.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$72K
- Restor3d, Inc.$5K
- Stryker$660
- Onkos Surgical, Inc.$105
- World Class Technology Corporation$80
Across 1 payment — averaging $3148.12 each. An ownership or investment interest held by the physician or an immediate family member.
- Restor3d, Inc.$3K
What the payments were for
- Consulting fees$57,94874%
- Travel & lodging$16,48121%
- Food & beverage$3,3914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 76 | $72,123 |
| Restor3d, Inc. | 6 | $4,853 |
| Stryker | 14 | $660 |
| Onkos Surgical, Inc. | 1 | $105 |
| World Class Technology Corporation | 1 | $80 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$51,149
- REAL INTELLIGENCE$30,922
- K-15 PORK$27,869
- Legion$13,000
- R3 ACETABULAR$6,694
- Navio Surgical System$5,475
- Tandem$5,250
- TRIGEN InterTAN$5,208
- Journey II BCS$3,815
- Journey II CR$3,600
- JOURNEY$1,322
- REDAPT$1,163
- OR3O$1,163
- POLAR3$1,163
- PICO$1,105
- POLARSTEM$1,085
- Legion Revision$1,014
- MAKO$460
- REDAPT Revision Hip System$267
- Anthology$215
How this compares
Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 43 | $724 |
| Meloxicam | 238 | $550 |
| Oxycodone Hcl | 35 | $234 |
| Tramadol Hcl | 78 | $217 |
| Amoxicillin | 77 | $126 |
| Mupirocin | 25 | $109 |
| Gabapentin | 26 | $96 |
| Ondansetron OdtOndansetron | 14 | $96 |
| Ondansetron Hcl | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Reno
- Michael RiesReno$7.7M
- Jackson JonesReno$37K
- Shay WarrenReno$23K
- Kingsley OladejiReno$21K
- Sanjai ShuklaReno$21K
- Timothy OmaraReno$8K
- Eric BoydenReno$7K
- Steven NishiyamaLas Vegas$836K
- Parminder KangLas Vegas$26K
- Justin LimtongLas Vegas$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.